Nancy D. Lin

2.5k total citations · 1 hit paper
22 papers, 1.9k citations indexed

About

Nancy D. Lin is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Nancy D. Lin has authored 22 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 6 papers in Economics and Econometrics. Recurrent topics in Nancy D. Lin's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Influenza Virus Research Studies (5 papers) and Pneumonia and Respiratory Infections (3 papers). Nancy D. Lin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Influenza Virus Research Studies (5 papers) and Pneumonia and Respiratory Infections (3 papers). Nancy D. Lin collaborates with scholars based in United States, Taiwan and United Kingdom. Nancy D. Lin's co-authors include Vandana Sundaram, Robyn Lewis, Ingram Olkin, Crystal Smith-Spangler, Dena M Bravata, Allison Gienger, John R. Sirard, Christopher D Stave, Michael A. Lauer and Eric J. Topol and has published in prestigious journals such as JAMA, PLoS ONE and The American Journal of Cardiology.

In The Last Decade

Nancy D. Lin

21 papers receiving 1.8k citations

Hit Papers

Using Pedometers to Increase Physical Activity and Improv... 2007 2026 2013 2019 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Using Pedometers to Increase Physical Activity and Improve Health
    2007 1.6k citations Dena M Bravata, Crystal Smith-Spangler et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy D. Lin United States 10 1.0k 580 576 307 235 22 1.9k
Barbara Ainsworth United States 11 1.0k 1.0× 866 1.5× 387 0.7× 160 0.5× 199 0.8× 17 2.4k
Nana Anokye United Kingdom 20 748 0.7× 512 0.9× 495 0.9× 183 0.6× 114 0.5× 76 2.0k
Felix Achana United Kingdom 18 1.0k 1.0× 1.0k 1.8× 473 0.8× 135 0.4× 202 0.9× 48 2.4k
Nipun Shrestha Australia 24 795 0.8× 672 1.2× 485 0.8× 146 0.5× 191 0.8× 63 1.9k
Maria Giné‐Garriga Spain 22 1.0k 1.0× 457 0.8× 499 0.9× 137 0.4× 78 0.3× 95 2.0k
Alison Kirk United Kingdom 29 998 1.0× 761 1.3× 666 1.2× 238 0.8× 204 0.9× 101 2.7k
Sarah M. Camhi United States 22 1.5k 1.4× 1.3k 2.2× 462 0.8× 131 0.4× 466 2.0× 52 2.7k
Stephen K. Epstein United States 17 513 0.5× 469 0.8× 596 1.0× 86 0.3× 511 2.2× 31 3.3k
Steven T. Johnson Canada 24 635 0.6× 392 0.7× 484 0.8× 162 0.5× 109 0.5× 102 1.8k
Robert G. Holleman United States 20 582 0.6× 362 0.6× 375 0.7× 113 0.4× 126 0.5× 39 1.3k

Countries citing papers authored by Nancy D. Lin

Since Specialization
Citations

This map shows the geographic impact of Nancy D. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy D. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy D. Lin more than expected).

Fields of papers citing papers by Nancy D. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy D. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy D. Lin. The network helps show where Nancy D. Lin may publish in the future.

Co-authorship network of co-authors of Nancy D. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy D. Lin. A scholar is included among the top collaborators of Nancy D. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy D. Lin. Nancy D. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mai, Xiaodan, Aaron B. Mendelsohn, James Marshall, et al.. (2024). Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States. Journal of Managed Care & Specialty Pharmacy. 30(10). 1160–1166. 1 indexed citations
2.
Lin, Nancy D., et al.. (2023). Considerations for defining medication exposure when analyzing real‐world data. Pharmacoepidemiology and Drug Safety. 32(8). 933–937. 1 indexed citations
3.
Liang, Caihua, Rachel P. Ogilvie, Michael Doherty, et al.. (2022). Trends in COVID-19 patient characteristics in a large electronic health record database in the United States: A cohort study. PLoS ONE. 17(7). e0271501–e0271501. 4 indexed citations
4.
Chomistek, Andrea K., Caihua Liang, Michael C. Doherty, et al.. (2022). Predictors of critical care, mechanical ventilation, and mortality among hospitalized patients with COVID-19 in an electronic health record database. BMC Infectious Diseases. 22(1). 413–413. 9 indexed citations
5.
Baker, Meghan A., Christopher Jankosky, W. Katherine Yih, et al.. (2020). The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines. Vaccine. 38(9). 2166–2171. 8 indexed citations
6.
7.
Haynes, Kevin, Sean D. Pokorney, Nancy D. Lin, et al.. (2020). Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial. Clinical Trials. 17(4). 360–367. 7 indexed citations
8.
Loughlin, Anita M., Nancy D. Lin, Victor Abler, & Benjamin Carroll. (2019). Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States. PLoS ONE. 14(6). e0216044–e0216044. 21 indexed citations
9.
Cocoros, Noelle M., Kevin Haynes, Qoua L. Her, et al.. (2019). Identification of potential drug name confusion errors in the Sentinel System. Pharmacoepidemiology and Drug Safety. 28(10). 1405–1410. 1 indexed citations
10.
11.
Cocoros, Noelle M., Sean D. Pokorney, Kevin Haynes, et al.. (2018). FDA-Catalyst—Using FDA’s Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial. Clinical Trials. 16(1). 90–97. 14 indexed citations
12.
Yih, W. Katherine, Sharon K. Greene, Martin Kulldorff, et al.. (2015). Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females. Vaccine. 34(1). 172–178. 16 indexed citations
13.
Lin, Nancy D., Heather Norman, Arie Regev, et al.. (2015). Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database. BMC Gastroenterology. 15(1). 134–134. 9 indexed citations
14.
McCarthy, Natalie, Julianne Gee, Nancy D. Lin, et al.. (2013). Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine. 31(50). 5975–5982. 17 indexed citations
15.
Thyagarajan, Veena, Julianne Gee, Jonathan Duffy, et al.. (2013). Identification of seizures among adults and children following influenza vaccination using health insurance claims data. Vaccine. 31(50). 5997–6002. 7 indexed citations
16.
Lin, Nancy D., Ken Kleinman, K. Arnold Chan, et al.. (2010). Multiple vaccinations and the risk of medically attended fever. Vaccine. 28(25). 4169–4174. 1 indexed citations
17.
Bravata, Dena M, Crystal Smith-Spangler, Vandana Sundaram, et al.. (2007). Using Pedometers to Increase Physical Activity and Improve Health. JAMA. 298(19). 2296–2296. 1636 indexed citations breakdown →
18.
Lin, Nancy D., Ken Kleinman, K. Arnold Chan, et al.. (2006). Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose. BMC Pediatrics. 6(1). 31–31. 5 indexed citations
19.
Lin, Nancy D., Ken Kleinman, K. Arnold Chan, et al.. (2005). Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants. BMC Pediatrics. 5(1). 43–43. 3 indexed citations
20.
Lauer, Michael A., et al.. (2002). Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997. The American Journal of Cardiology. 89(8). 924–929. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Ainsworth Breakdown of academic impact, for papers by Nana Anokye Breakdown of academic impact, for papers by Felix Achana Breakdown of academic impact, for papers by Nipun Shrestha Breakdown of academic impact, for papers by Maria Giné‐Garriga Breakdown of academic impact, for papers by Alison Kirk Breakdown of academic impact, for papers by Sarah M. Camhi Breakdown of academic impact, for papers by Stephen K. Epstein Breakdown of academic impact, for papers by Steven T. Johnson Breakdown of academic impact, for papers by Robert G. Holleman
Rankless by CCL
2026